Biotech Law

Sandage, Jr., Coronado’s President and CEO, will present at the 19th Annual Future Leaders in the Biotech Industry Conference on Friday … except as required by law.

Could something have escaped from the local biotech facility? The local biotech facility is owned by the Godfrey family – Norman (Scott) plus sister-in-law Olivia (Janssen), the ‘freakish’ daughter Shelly (an homage to Frankenstein?),

This law is a bad investment; we’re raising a generation of students who won’t be prepared for jobs in the global biotech industry — an industry dominating everything from medicine to agriculture to nanotechnology. Sen. Karen Carter Peterson …

Proponents of the law, House Bill (HB) 368/Senate Bill 893, maintain that its purpose is simply to encourage scepticism and evidence-based reasoning. “Critical thinking fosters good science,” said Robin Zimmer, a biotechnology consultant and affiliate …

Now, an attorney and law professor from the UCLA School of Law and a member … has been that scientists and biotechnology companies are initially going after the so-called low-hanging fruit of stem cell treatments — those projects that appear … Continue reading →

Now, an attorney and law professor from the UCLA School of Law and a member … has been that scientists and biotechnology companies are initially going after the so-called low-hanging fruit of stem cell treatments — those projects that …

NEW YORK, NY–(Marketwire -03/28/12)- Biotechnology stocks have been on an impressive … established in the health care reform law. BIO also issued a press release applauding the Senate on the passage of H.R. 3606, the Jumpstart Our Business …

Access to the full company reports can be found at: www.fivestarequities.com/GERN www.fivestarequities.com/ATHX “This law will incentivize and encourage capital formation for small, emerging biotechnology companies that do not yet have products on the …

“This law will incentivize and encourage capital formation for small, emerging biotechnology companies that do not yet have products on the market,” BIO President and CEO Jim Greenwood stated. “By allowing companies to focus their limited funds on research …

Access to the full company reports can be found at: “This law will incentivize and encourage capital formation for small, emerging biotechnology companies that do not yet have products on the market,” BIO President and CEO Jim Greenwood stated.